Upregulation of ENAH by a PI3K/AKT/β-catenin cascade promotes oral cancer cell migration and growth via an ITGB5/Src axis

Oral cancer accounts for 2% of cancer-related deaths globally, with over 90% of cases being oral cavity squamous cell carcinomas (OSCCs). Approximately 50% of patients with OSCC succumb to the disease within 5 years, primarily due to the advanced stage at which it is typically diagnosed. This unders...

Full description

Saved in:
Bibliographic Details
Published inCellular & molecular biology letters Vol. 29; no. 1; pp. 136 - 25
Main Authors Chan, Xiu-Ya, Chang, Kai-Ping, Yang, Chia-Yu, Liu, Chiao-Rou, Hung, Chu-Mi, Huang, Chun-Chueh, Liu, Hao-Ping, Wu, Chih-Ching
Format Journal Article
LanguageEnglish
Published England BioMed Central 07.11.2024
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Oral cancer accounts for 2% of cancer-related deaths globally, with over 90% of cases being oral cavity squamous cell carcinomas (OSCCs). Approximately 50% of patients with OSCC succumb to the disease within 5 years, primarily due to the advanced stage at which it is typically diagnosed. This underscores an urgent need to identify proteins related to OSCC progression to develop effective diagnostic and therapeutic strategies. To identify OSCC progression-related proteins, we conducted integrated proteome and transcriptome analyses on cancer tissues from patients and patient-derived xenograft (PDX) model mice. We investigated the role of protein-enabled homolog (ENAH), identified as an OSCC progression-associated protein, through proliferation, transwell migration, and invasion assays in OSCC cells. The mechanisms underlying ENAH-mediated functions were elucidated using gene knockdown and ectopic expression techniques in OSCC cells. ENAH was identified as a candidate associated with OSCC progression based on integrated analyses, which showed increased ENAH levels in primary OSCC tissues compared with adjacent noncancerous counterparts, and sustained overexpression in the cancer tissues of PDX models. We confirmed that level of ENAH is increased in OSCC tissues and that its elevated expression correlates with poorer survival rates in patients with OSCC. Furthermore, the upregulation of ENAH in OSCC cells results from the activation of the GSK3β/β-catenin axis by the EGFR/PI3K/AKT cascade. ENAH expression enhances cell proliferation and mobility by upregulating integrin β5 in oral cancer cells. The upregulation of ENAH through a PI3K/AKT/β-catenin signaling cascade enhances oral cancer cell migration and growth via the ITGB5/Src axis. These findings offer a new interpretation of the ENAH function in the OSCC progression and provide crucial information for developing new OSCC treatment strategies.
AbstractList Oral cancer accounts for 2% of cancer-related deaths globally, with over 90% of cases being oral cavity squamous cell carcinomas (OSCCs). Approximately 50% of patients with OSCC succumb to the disease within 5 years, primarily due to the advanced stage at which it is typically diagnosed. This underscores an urgent need to identify proteins related to OSCC progression to develop effective diagnostic and therapeutic strategies.BACKGROUNDOral cancer accounts for 2% of cancer-related deaths globally, with over 90% of cases being oral cavity squamous cell carcinomas (OSCCs). Approximately 50% of patients with OSCC succumb to the disease within 5 years, primarily due to the advanced stage at which it is typically diagnosed. This underscores an urgent need to identify proteins related to OSCC progression to develop effective diagnostic and therapeutic strategies.To identify OSCC progression-related proteins, we conducted integrated proteome and transcriptome analyses on cancer tissues from patients and patient-derived xenograft (PDX) model mice. We investigated the role of protein-enabled homolog (ENAH), identified as an OSCC progression-associated protein, through proliferation, transwell migration, and invasion assays in OSCC cells. The mechanisms underlying ENAH-mediated functions were elucidated using gene knockdown and ectopic expression techniques in OSCC cells.METHODSTo identify OSCC progression-related proteins, we conducted integrated proteome and transcriptome analyses on cancer tissues from patients and patient-derived xenograft (PDX) model mice. We investigated the role of protein-enabled homolog (ENAH), identified as an OSCC progression-associated protein, through proliferation, transwell migration, and invasion assays in OSCC cells. The mechanisms underlying ENAH-mediated functions were elucidated using gene knockdown and ectopic expression techniques in OSCC cells.ENAH was identified as a candidate associated with OSCC progression based on integrated analyses, which showed increased ENAH levels in primary OSCC tissues compared with adjacent noncancerous counterparts, and sustained overexpression in the cancer tissues of PDX models. We confirmed that level of ENAH is increased in OSCC tissues and that its elevated expression correlates with poorer survival rates in patients with OSCC. Furthermore, the upregulation of ENAH in OSCC cells results from the activation of the GSK3β/β-catenin axis by the EGFR/PI3K/AKT cascade. ENAH expression enhances cell proliferation and mobility by upregulating integrin β5 in oral cancer cells.RESULTSENAH was identified as a candidate associated with OSCC progression based on integrated analyses, which showed increased ENAH levels in primary OSCC tissues compared with adjacent noncancerous counterparts, and sustained overexpression in the cancer tissues of PDX models. We confirmed that level of ENAH is increased in OSCC tissues and that its elevated expression correlates with poorer survival rates in patients with OSCC. Furthermore, the upregulation of ENAH in OSCC cells results from the activation of the GSK3β/β-catenin axis by the EGFR/PI3K/AKT cascade. ENAH expression enhances cell proliferation and mobility by upregulating integrin β5 in oral cancer cells.The upregulation of ENAH through a PI3K/AKT/β-catenin signaling cascade enhances oral cancer cell migration and growth via the ITGB5/Src axis. These findings offer a new interpretation of the ENAH function in the OSCC progression and provide crucial information for developing new OSCC treatment strategies.CONCLUSIONSThe upregulation of ENAH through a PI3K/AKT/β-catenin signaling cascade enhances oral cancer cell migration and growth via the ITGB5/Src axis. These findings offer a new interpretation of the ENAH function in the OSCC progression and provide crucial information for developing new OSCC treatment strategies.
BackgroundOral cancer accounts for 2% of cancer-related deaths globally, with over 90% of cases being oral cavity squamous cell carcinomas (OSCCs). Approximately 50% of patients with OSCC succumb to the disease within 5 years, primarily due to the advanced stage at which it is typically diagnosed. This underscores an urgent need to identify proteins related to OSCC progression to develop effective diagnostic and therapeutic strategies.MethodsTo identify OSCC progression-related proteins, we conducted integrated proteome and transcriptome analyses on cancer tissues from patients and patient-derived xenograft (PDX) model mice. We investigated the role of protein-enabled homolog (ENAH), identified as an OSCC progression-associated protein, through proliferation, transwell migration, and invasion assays in OSCC cells. The mechanisms underlying ENAH-mediated functions were elucidated using gene knockdown and ectopic expression techniques in OSCC cells.ResultsENAH was identified as a candidate associated with OSCC progression based on integrated analyses, which showed increased ENAH levels in primary OSCC tissues compared with adjacent noncancerous counterparts, and sustained overexpression in the cancer tissues of PDX models. We confirmed that level of ENAH is increased in OSCC tissues and that its elevated expression correlates with poorer survival rates in patients with OSCC. Furthermore, the upregulation of ENAH in OSCC cells results from the activation of the GSK3β/β-catenin axis by the EGFR/PI3K/AKT cascade. ENAH expression enhances cell proliferation and mobility by upregulating integrin β5 in oral cancer cells.ConclusionsThe upregulation of ENAH through a PI3K/AKT/β-catenin signaling cascade enhances oral cancer cell migration and growth via the ITGB5/Src axis. These findings offer a new interpretation of the ENAH function in the OSCC progression and provide crucial information for developing new OSCC treatment strategies.
Abstract Background Oral cancer accounts for 2% of cancer-related deaths globally, with over 90% of cases being oral cavity squamous cell carcinomas (OSCCs). Approximately 50% of patients with OSCC succumb to the disease within 5 years, primarily due to the advanced stage at which it is typically diagnosed. This underscores an urgent need to identify proteins related to OSCC progression to develop effective diagnostic and therapeutic strategies. Methods To identify OSCC progression-related proteins, we conducted integrated proteome and transcriptome analyses on cancer tissues from patients and patient-derived xenograft (PDX) model mice. We investigated the role of protein-enabled homolog (ENAH), identified as an OSCC progression-associated protein, through proliferation, transwell migration, and invasion assays in OSCC cells. The mechanisms underlying ENAH-mediated functions were elucidated using gene knockdown and ectopic expression techniques in OSCC cells. Results ENAH was identified as a candidate associated with OSCC progression based on integrated analyses, which showed increased ENAH levels in primary OSCC tissues compared with adjacent noncancerous counterparts, and sustained overexpression in the cancer tissues of PDX models. We confirmed that level of ENAH is increased in OSCC tissues and that its elevated expression correlates with poorer survival rates in patients with OSCC. Furthermore, the upregulation of ENAH in OSCC cells results from the activation of the GSK3β/β-catenin axis by the EGFR/PI3K/AKT cascade. ENAH expression enhances cell proliferation and mobility by upregulating integrin β5 in oral cancer cells. Conclusions The upregulation of ENAH through a PI3K/AKT/β-catenin signaling cascade enhances oral cancer cell migration and growth via the ITGB5/Src axis. These findings offer a new interpretation of the ENAH function in the OSCC progression and provide crucial information for developing new OSCC treatment strategies.
Oral cancer accounts for 2% of cancer-related deaths globally, with over 90% of cases being oral cavity squamous cell carcinomas (OSCCs). Approximately 50% of patients with OSCC succumb to the disease within 5 years, primarily due to the advanced stage at which it is typically diagnosed. This underscores an urgent need to identify proteins related to OSCC progression to develop effective diagnostic and therapeutic strategies. To identify OSCC progression-related proteins, we conducted integrated proteome and transcriptome analyses on cancer tissues from patients and patient-derived xenograft (PDX) model mice. We investigated the role of protein-enabled homolog (ENAH), identified as an OSCC progression-associated protein, through proliferation, transwell migration, and invasion assays in OSCC cells. The mechanisms underlying ENAH-mediated functions were elucidated using gene knockdown and ectopic expression techniques in OSCC cells. ENAH was identified as a candidate associated with OSCC progression based on integrated analyses, which showed increased ENAH levels in primary OSCC tissues compared with adjacent noncancerous counterparts, and sustained overexpression in the cancer tissues of PDX models. We confirmed that level of ENAH is increased in OSCC tissues and that its elevated expression correlates with poorer survival rates in patients with OSCC. Furthermore, the upregulation of ENAH in OSCC cells results from the activation of the GSK3β/β-catenin axis by the EGFR/PI3K/AKT cascade. ENAH expression enhances cell proliferation and mobility by upregulating integrin β5 in oral cancer cells. The upregulation of ENAH through a PI3K/AKT/β-catenin signaling cascade enhances oral cancer cell migration and growth via the ITGB5/Src axis. These findings offer a new interpretation of the ENAH function in the OSCC progression and provide crucial information for developing new OSCC treatment strategies.
ArticleNumber 136
Author Chang, Kai-Ping
Hung, Chu-Mi
Chan, Xiu-Ya
Wu, Chih-Ching
Yang, Chia-Yu
Liu, Hao-Ping
Huang, Chun-Chueh
Liu, Chiao-Rou
Author_xml – sequence: 1
  givenname: Xiu-Ya
  surname: Chan
  fullname: Chan, Xiu-Ya
– sequence: 2
  givenname: Kai-Ping
  surname: Chang
  fullname: Chang, Kai-Ping
– sequence: 3
  givenname: Chia-Yu
  surname: Yang
  fullname: Yang, Chia-Yu
– sequence: 4
  givenname: Chiao-Rou
  surname: Liu
  fullname: Liu, Chiao-Rou
– sequence: 5
  givenname: Chu-Mi
  surname: Hung
  fullname: Hung, Chu-Mi
– sequence: 6
  givenname: Chun-Chueh
  surname: Huang
  fullname: Huang, Chun-Chueh
– sequence: 7
  givenname: Hao-Ping
  surname: Liu
  fullname: Liu, Hao-Ping
– sequence: 8
  givenname: Chih-Ching
  orcidid: 0000-0002-7264-9672
  surname: Wu
  fullname: Wu, Chih-Ching
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39511483$$D View this record in MEDLINE/PubMed
BookMark eNpdkstu1DAUhi1URC_wAiyQJTZswvg-znKoSjtqBUhM19axYw8ZJfFgJ0B5LB6EZ8LTlAqxsn306dM5x_8pOhri4BF6SclbSrVaZEqV1BVhoiJESVqRJ-iEKl1XlNfs6J_7MTrNeUcII0KQZ-iY15JSofkJ-nm7T347dTC2ccAx4IsPqyts7zDgT2t-vVhdbxa_f1UORj-0A3aQHTQe71Ps4-gzjgm6Uh2cT9j5rsN9u02zDIYGb1P8Pn7B31ooT7zeXL6Ti8_JYfjR5ufoaYAu-xcP5xm6fX-xOb-qbj5ers9XN5UrnY-VZ5JTUMrLmiytbhraMKskyGVQIdSMUquWlhJJfGgUdc46KYQDAEqYDY6fofXsbSLszD61PaQ7E6E194WYtgbS2LrOG64VMC2Kqw6CEQaNFZbUXBFPglKkuN7MrrKAr5PPo-nbfJgbBh-nbDhlmjMhlCzo6__QXZzSUCY9UFIvmdB1oV49UJPtffPY3t8fKgCbAZdizsmHR4QSc4iBmWNgSgzMfQwM4X8AxOCiCw
Cites_doi 10.3389/fonc.2022.809589
10.1016/j.gene.2016.03.003
10.1038/s41568-019-0216-7
10.3389/fonc.2022.792297
10.1016/j.suronc.2019.09.001
10.1080/2162402X.2016.1221556
10.52586/4946
10.3390/ijerph17020665
10.3389/fonc.2020.00352
10.1038/srep35298
10.1158/1541-7786.MCR-15-0354
10.15252/embr.202050078
10.1038/s41419-019-1320-z
10.1007/s12094-018-02025-3
10.1186/s13045-020-01021-x
10.1002/cam4.6652
10.3892/ol.2016.5500
10.1073/pnas.2007213117
10.1155/2022/5501476
10.1242/jcs.220814
10.1038/s41467-017-00493-9
10.1038/s41419-018-1031-x
10.3892/etm.2010.171
10.1371/journal.pone.0037013
10.1038/s41392-023-01419-2
10.1002/cam4.4163
10.1091/mbc.e06-11-0990
10.1038/s41598-024-64264-5
10.1016/j.cell.2017.05.016
10.1016/j.cellsig.2020.109692
10.1073/pnas.1715998115
10.1038/s41392-021-00701-5
10.1186/s12964-023-01264-4
10.3389/fonc.2022.1052375
10.1158/1078-0432.CCR-07-1041
10.1038/s41388-018-0364-3
10.1007/s12551-013-0124-0
10.1083/jcb.201003014
10.1080/21655979.2021.1977103
10.3389/fmolb.2020.590912
10.1093/narcan/zcaa021
10.1097/CM9.0000000000002108
10.1073/pnas.1214394109
10.1016/j.heliyon.2024.e28406
10.1074/mcp.RA119.001530
10.1038/s41392-022-01297-0
10.3389/fonc.2021.750852
10.1016/j.aca.2018.10.070
10.4103/jcar.JCar_17_18
10.3390/cancers12071726
10.1186/s13046-019-1091-5
10.3322/caac.21820
10.1158/1078-0432.CCR-05-2027
10.1146/annurev.cellbio.19.050103.103356
10.1016/j.bbagrm.2019.04.006
10.1161/ATVBAHA.110.206086
ContentType Journal Article
Copyright 2024. The Author(s).
The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2024. The Author(s).
– notice: The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88A
88E
8AO
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M7P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
7X8
DOA
DOI 10.1186/s11658-024-00651-0
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Databases
Natural Science Collection
ProQuest One Community College
ProQuest Central
Proquest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Medical Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
Publicly Available Content Database

MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1689-1392
EndPage 25
ExternalDocumentID oai_doaj_org_article_386a2840509f4202adb4b09360e0f660
39511483
10_1186_s11658_024_00651_0
Genre Journal Article
GeographicLocations United States--US
Taiwan
GeographicLocations_xml – name: Taiwan
– name: United States--US
GrantInformation_xml – fundername: Chang Gung Memorial Hospital, Linkou
  grantid: CMRPG3M0101
– fundername: Chang Gung Memorial Hospital, Linkou
  grantid: CLRPD1J0015
– fundername: National Science and Technology Council
  grantid: 111-2314-B-182A-078-MY3
– fundername: National Science and Technology Council
  grantid: 112-2320-B-182-044
– fundername: Chang Gung Memorial Hospital, Linkou
  grantid: BMRPC77
– fundername: Chang Gung Memorial Hospital, Linkou
  grantid: CMRPG3J1253
GroupedDBID ---
.86
.VR
06D
0R~
0VY
29B
2JY
2~H
30V
4.4
408
53G
5GY
67N
67Z
6NX
6S1
7X7
88E
8AO
8FI
8FJ
8TC
8UJ
95.
95~
AAFWJ
AAJSJ
AAKDD
AAQCX
AASML
AASQH
AAXMT
AAYXX
ABAQN
ABFKT
ABMNI
ABUWG
ACGFS
ACOMO
ACPRK
ACZBO
ADBBV
ADGYE
ADOZN
ADUKV
AENEX
AFBAA
AFBBN
AFCXV
AFKRA
AFPKN
AFWTZ
AHBYD
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AOIJS
BA0
BAPOH
BAWUL
BBNVY
BCNDV
BENPR
BFQNJ
BHPHI
BMC
C6C
CCPQU
CITATION
CS3
DU5
E3Z
EBLON
EBS
EMOBN
F5P
FRP
FYUFA
G-Y
G-Z
GQ7
GROUPED_DOAJ
GX1
HCIFZ
HF~
HLICF
HMCUK
HMJXF
HYE
IJ-
IXC
IXE
IY9
IZQ
I~X
I~Z
KDC
KOV
M1P
M7P
MA-
N9A
OAM
OK1
PF0
PHGZM
PHGZT
PIMPY
PSQYO
QOS
R9I
RBZ
RNS
ROL
RPM
RPX
RSV
S27
S3A
S3B
SBL
SDH
SHX
SOJ
T13
TR2
TSK
TSV
TUC
U2A
UKHRP
VC2
WK8
XSB
Y2W
~A9
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
PQGLB
3V.
7XB
88A
8FE
8FH
8FK
AZQEC
DWQXO
GNUQQ
K9.
LK8
PKEHL
PQEST
PQQKQ
PQUKI
7X8
PUEGO
ID FETCH-LOGICAL-c392t-e2531a66e5907b8dd1d2b65a57f6ff9211b67b1050efd61ccbc544caaa102bfc3
IEDL.DBID DOA
ISSN 1689-1392
1425-8153
IngestDate Wed Aug 27 01:27:49 EDT 2025
Fri Jul 11 04:10:28 EDT 2025
Fri Jul 25 19:24:28 EDT 2025
Mon Jul 21 06:07:18 EDT 2025
Tue Jul 01 03:25:18 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Integrin β5 (ITGB5)
Oral cavity squamous cell carcinoma (OSCC)
Patient-derived xenograft (PDX)
GSK3β/β-catenin signaling
Protein-enabled homolog (ENAH)
Proteomics
Language English
License 2024. The Author(s).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c392t-e2531a66e5907b8dd1d2b65a57f6ff9211b67b1050efd61ccbc544caaa102bfc3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-7264-9672
OpenAccessLink https://doaj.org/article/386a2840509f4202adb4b09360e0f660
PMID 39511483
PQID 3125872489
PQPubID 54771
PageCount 25
ParticipantIDs doaj_primary_oai_doaj_org_article_386a2840509f4202adb4b09360e0f660
proquest_miscellaneous_3128324465
proquest_journals_3125872489
pubmed_primary_39511483
crossref_primary_10_1186_s11658_024_00651_0
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-11-07
PublicationDateYYYYMMDD 2024-11-07
PublicationDate_xml – month: 11
  year: 2024
  text: 2024-11-07
  day: 07
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: Wrocław
PublicationTitle Cellular & molecular biology letters
PublicationTitleAlternate Cell Mol Biol Lett
PublicationYear 2024
Publisher BioMed Central
BMC
Publisher_xml – name: BioMed Central
– name: BMC
References G Hoxhaj (651_CR20) 2020; 20
M Balsamo (651_CR35) 2016; 6
Y Yamada (651_CR27) 2018; 52
FA Ribeiro (651_CR55) 2014; 34
S Lakshminarayana (651_CR17) 2018; 17
S Li (651_CR21) 2023; 21
H Li (651_CR11) 2016; 14
Y Zhu (651_CR33) 2022; 2022
F Di Modugno (651_CR42) 2018; 37
WC Yen (651_CR10) 2022; 12
S Li (651_CR50) 2019; 1862
WC Huang (651_CR23) 2019; 38
F Di Modugno (651_CR49) 2012; 109
TW Chen (651_CR16) 2017; 8
L Zhou (651_CR28) 2022; 12
H Zhang (651_CR30) 2019; 10
L Satgunaseelan (651_CR53) 2021; 11
AA Molinolo (651_CR6) 2007; 13
A Najafov (651_CR19) 2012; 7
Y Zhang (651_CR31) 2021; 26
HW Chu (651_CR13) 2019; 18
F Guo (651_CR44) 2016; 584
C Xia (651_CR4) 2022; 135
Z Chi (651_CR29) 2024; 14
M Antoine (651_CR39) 2020; 73
N Ahuja (651_CR48) 2020; 2
CW Hsu (651_CR5) 2019; 1050
VA Jones (651_CR25) 2020; 10
RL Siegel (651_CR1) 2024; 74
M Barone (651_CR59) 2020; 117
R Melchionna (651_CR43) 2016; 5
SY Kao (651_CR3) 2015; 18
LC Hung (651_CR2) 2020; 17
Q Liu (651_CR32) 2021; 14
Y Liu (651_CR24) 2023; 8
L Zhang (651_CR58) 2019; 21
Y Ohnishi (651_CR18) 2017; 13
J Wang (651_CR34) 2021; 10
X Zhang (651_CR46) 2023; 12
LE Young (651_CR14) 2018; 131
L Liu (651_CR54) 2019; 31
EM Fabricius (651_CR57) 2011; 2
S Na (651_CR45) 2022; 12
LR Anderson (651_CR56) 2014; 6
J Xie (651_CR8) 2020; 7
B Ning (651_CR26) 2021; 12
F Di Modugno (651_CR41) 2006; 12
CY Yang (651_CR12) 2020; 12
SD Hansen (651_CR36) 2010; 191
DA Applewhite (651_CR40) 2007; 18
F Di Modugno (651_CR51) 2018; 115
R Nusse (651_CR47) 2017; 169
F Yu (651_CR9) 2021; 6
Q Li (651_CR7) 2023; 8
M Leifheit-Nestler (651_CR22) 2010; 30
R Melchionna (651_CR38) 2020; 21
HC Chang (651_CR52) 2024; 10
M Krause (651_CR37) 2003; 19
D Chen (651_CR15) 2018; 9
References_xml – volume: 12
  year: 2022
  ident: 651_CR28
  publication-title: Front Oncol
  doi: 10.3389/fonc.2022.809589
– volume: 584
  start-page: 31
  issue: 1
  year: 2016
  ident: 651_CR44
  publication-title: Gene
  doi: 10.1016/j.gene.2016.03.003
– volume: 20
  start-page: 74
  issue: 2
  year: 2020
  ident: 651_CR20
  publication-title: Nat Rev Cancer
  doi: 10.1038/s41568-019-0216-7
– volume: 12
  year: 2022
  ident: 651_CR10
  publication-title: Front Oncol
  doi: 10.3389/fonc.2022.792297
– volume: 31
  start-page: 90
  year: 2019
  ident: 651_CR54
  publication-title: Surg Oncol
  doi: 10.1016/j.suronc.2019.09.001
– volume: 5
  issue: 12
  year: 2016
  ident: 651_CR43
  publication-title: Oncoimmunology
  doi: 10.1080/2162402X.2016.1221556
– volume: 26
  start-page: 322
  issue: 8
  year: 2021
  ident: 651_CR31
  publication-title: Front Biosci
  doi: 10.52586/4946
– volume: 17
  start-page: 665
  issue: 2
  year: 2020
  ident: 651_CR2
  publication-title: Int J Environ Res Public Health
  doi: 10.3390/ijerph17020665
– volume: 10
  start-page: 352
  year: 2020
  ident: 651_CR25
  publication-title: Front Oncol
  doi: 10.3389/fonc.2020.00352
– volume: 6
  start-page: 35298
  year: 2016
  ident: 651_CR35
  publication-title: Sci Rep
  doi: 10.1038/srep35298
– volume: 14
  start-page: 278
  issue: 3
  year: 2016
  ident: 651_CR11
  publication-title: Mol Cancer Res
  doi: 10.1158/1541-7786.MCR-15-0354
– volume: 21
  issue: 11
  year: 2020
  ident: 651_CR38
  publication-title: EMBO Rep
  doi: 10.15252/embr.202050078
– volume: 10
  start-page: 230
  issue: 3
  year: 2019
  ident: 651_CR30
  publication-title: Cell Death Dis
  doi: 10.1038/s41419-019-1320-z
– volume: 21
  start-page: 1052
  issue: 8
  year: 2019
  ident: 651_CR58
  publication-title: Clin Transl Oncol
  doi: 10.1007/s12094-018-02025-3
– volume: 14
  start-page: 6
  issue: 1
  year: 2021
  ident: 651_CR32
  publication-title: J Hematol Oncol
  doi: 10.1186/s13045-020-01021-x
– volume: 12
  start-page: 20892
  issue: 22
  year: 2023
  ident: 651_CR46
  publication-title: Cancer Med
  doi: 10.1002/cam4.6652
– volume: 13
  start-page: 930
  issue: 2
  year: 2017
  ident: 651_CR18
  publication-title: Oncol Lett
  doi: 10.3892/ol.2016.5500
– volume: 117
  start-page: 29684
  issue: 47
  year: 2020
  ident: 651_CR59
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.2007213117
– volume: 2022
  start-page: 5501476
  year: 2022
  ident: 651_CR33
  publication-title: J Immunol Res
  doi: 10.1155/2022/5501476
– volume: 131
  start-page: jcs220814
  issue: 21
  year: 2018
  ident: 651_CR14
  publication-title: J Cell Sci
  doi: 10.1242/jcs.220814
– volume: 8
  start-page: 465
  issue: 1
  year: 2017
  ident: 651_CR16
  publication-title: Nat Commun
  doi: 10.1038/s41467-017-00493-9
– volume: 9
  start-page: 998
  issue: 10
  year: 2018
  ident: 651_CR15
  publication-title: Cell Death Dis
  doi: 10.1038/s41419-018-1031-x
– volume: 2
  start-page: 9
  issue: 1
  year: 2011
  ident: 651_CR57
  publication-title: Exp Ther Med
  doi: 10.3892/etm.2010.171
– volume: 7
  issue: 5
  year: 2012
  ident: 651_CR19
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0037013
– volume: 8
  start-page: 160
  issue: 1
  year: 2023
  ident: 651_CR24
  publication-title: Signal Transduct Target Ther
  doi: 10.1038/s41392-023-01419-2
– volume: 10
  start-page: 6515
  issue: 18
  year: 2021
  ident: 651_CR34
  publication-title: Cancer Med
  doi: 10.1002/cam4.4163
– volume: 34
  start-page: 1547
  issue: 4
  year: 2014
  ident: 651_CR55
  publication-title: Anticancer Res
– volume: 18
  start-page: 2579
  issue: 7
  year: 2007
  ident: 651_CR40
  publication-title: Mol Biol Cell
  doi: 10.1091/mbc.e06-11-0990
– volume: 14
  start-page: 15023
  issue: 1
  year: 2024
  ident: 651_CR29
  publication-title: Sci Rep
  doi: 10.1038/s41598-024-64264-5
– volume: 18
  start-page: 7
  issue: 1
  year: 2015
  ident: 651_CR3
  publication-title: Chin J Dent Res
– volume: 169
  start-page: 985
  issue: 6
  year: 2017
  ident: 651_CR47
  publication-title: Cell
  doi: 10.1016/j.cell.2017.05.016
– volume: 73
  year: 2020
  ident: 651_CR39
  publication-title: Cell Signal
  doi: 10.1016/j.cellsig.2020.109692
– volume: 115
  start-page: 3132
  issue: 12
  year: 2018
  ident: 651_CR51
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1715998115
– volume: 6
  start-page: 307
  issue: 1
  year: 2021
  ident: 651_CR9
  publication-title: Signal Transduct Target Ther
  doi: 10.1038/s41392-021-00701-5
– volume: 21
  start-page: 266
  issue: 1
  year: 2023
  ident: 651_CR21
  publication-title: Cell Commun Signal
  doi: 10.1186/s12964-023-01264-4
– volume: 12
  start-page: 1052375
  year: 2022
  ident: 651_CR45
  publication-title: Front Oncol
  doi: 10.3389/fonc.2022.1052375
– volume: 13
  start-page: 4964
  issue: 17
  year: 2007
  ident: 651_CR6
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-07-1041
– volume: 37
  start-page: 5605
  issue: 42
  year: 2018
  ident: 651_CR42
  publication-title: Oncogene
  doi: 10.1038/s41388-018-0364-3
– volume: 6
  start-page: 203
  issue: 2
  year: 2014
  ident: 651_CR56
  publication-title: Biophys Rev
  doi: 10.1007/s12551-013-0124-0
– volume: 191
  start-page: 571
  issue: 3
  year: 2010
  ident: 651_CR36
  publication-title: J Cell Biol
  doi: 10.1083/jcb.201003014
– volume: 12
  start-page: 7907
  issue: 1
  year: 2021
  ident: 651_CR26
  publication-title: Bioengineered
  doi: 10.1080/21655979.2021.1977103
– volume: 7
  year: 2020
  ident: 651_CR8
  publication-title: Front Mol Biosci
  doi: 10.3389/fmolb.2020.590912
– volume: 2
  start-page: zcaa021
  issue: 3
  year: 2020
  ident: 651_CR48
  publication-title: NAR Cancer
  doi: 10.1093/narcan/zcaa021
– volume: 135
  start-page: 584
  issue: 5
  year: 2022
  ident: 651_CR4
  publication-title: Chin Med J (Engl)
  doi: 10.1097/CM9.0000000000002108
– volume: 109
  start-page: 19280
  issue: 47
  year: 2012
  ident: 651_CR49
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1214394109
– volume: 10
  issue: 6
  year: 2024
  ident: 651_CR52
  publication-title: Heliyon
  doi: 10.1016/j.heliyon.2024.e28406
– volume: 18
  start-page: 1796
  issue: 9
  year: 2019
  ident: 651_CR13
  publication-title: Mol Cell Proteomics
  doi: 10.1074/mcp.RA119.001530
– volume: 52
  start-page: 166
  issue: 1
  year: 2018
  ident: 651_CR27
  publication-title: Int J Oncol
– volume: 8
  start-page: 31
  issue: 1
  year: 2023
  ident: 651_CR7
  publication-title: Signal Transduct Target Ther
  doi: 10.1038/s41392-022-01297-0
– volume: 11
  year: 2021
  ident: 651_CR53
  publication-title: Front Oncol
  doi: 10.3389/fonc.2021.750852
– volume: 1050
  start-page: 113
  year: 2019
  ident: 651_CR5
  publication-title: Anal Chim Acta
  doi: 10.1016/j.aca.2018.10.070
– volume: 17
  start-page: 7
  year: 2018
  ident: 651_CR17
  publication-title: J Carcinog
  doi: 10.4103/jcar.JCar_17_18
– volume: 12
  start-page: 1726
  issue: 7
  year: 2020
  ident: 651_CR12
  publication-title: Cancers
  doi: 10.3390/cancers12071726
– volume: 38
  start-page: 89
  issue: 1
  year: 2019
  ident: 651_CR23
  publication-title: J Exp Clin Cancer Res
  doi: 10.1186/s13046-019-1091-5
– volume: 74
  start-page: 12
  issue: 1
  year: 2024
  ident: 651_CR1
  publication-title: CA Cancer J, Clin
  doi: 10.3322/caac.21820
– volume: 12
  start-page: 1470
  issue: 5
  year: 2006
  ident: 651_CR41
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-05-2027
– volume: 19
  start-page: 541
  year: 2003
  ident: 651_CR37
  publication-title: Annu Rev Cell Dev Biol
  doi: 10.1146/annurev.cellbio.19.050103.103356
– volume: 1862
  start-page: 858
  issue: 8
  year: 2019
  ident: 651_CR50
  publication-title: Biochim Biophys Acta Gene Regul Mech
  doi: 10.1016/j.bbagrm.2019.04.006
– volume: 30
  start-page: 1398
  issue: 7
  year: 2010
  ident: 651_CR22
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/ATVBAHA.110.206086
SSID ssj0020440
Score 2.3723485
Snippet Oral cancer accounts for 2% of cancer-related deaths globally, with over 90% of cases being oral cavity squamous cell carcinomas (OSCCs). Approximately 50% of...
BackgroundOral cancer accounts for 2% of cancer-related deaths globally, with over 90% of cases being oral cavity squamous cell carcinomas (OSCCs)....
Abstract Background Oral cancer accounts for 2% of cancer-related deaths globally, with over 90% of cases being oral cavity squamous cell carcinomas (OSCCs)....
SourceID doaj
proquest
pubmed
crossref
SourceType Open Website
Aggregation Database
Index Database
StartPage 136
SubjectTerms 1-Phosphatidylinositol 3-kinase
AKT protein
Animal models
Animals
beta Catenin - genetics
beta Catenin - metabolism
Cell activation
Cell culture
Cell Line, Tumor
Cell migration
Cell Movement - genetics
Cell proliferation
Cell Proliferation - genetics
Cell survival
Clinical trials
Ectopic expression
Epidermal growth factor
Female
Gene Expression Regulation, Neoplastic
GSK3β/β-catenin signaling
Head & neck cancer
Humans
Immunohistochemistry
Integrin beta Chains - genetics
Integrin beta Chains - metabolism
Integrin β5 (ITGB5)
Male
Mass spectrometry
Medical prognosis
Medical research
Metastasis
Mice
Mice, Nude
Mouth Neoplasms - genetics
Mouth Neoplasms - metabolism
Mouth Neoplasms - pathology
Oral cancer
Oral carcinoma
Oral cavity
Oral cavity squamous cell carcinoma (OSCC)
Patient-derived xenograft (PDX)
Patients
Peptides
Phosphatidylinositol 3-Kinases - genetics
Phosphatidylinositol 3-Kinases - metabolism
Protein-enabled homolog (ENAH)
Proteins
Proteomes
Proteomics
Proto-Oncogene Proteins c-akt - genetics
Proto-Oncogene Proteins c-akt - metabolism
Ratios
Scientific imaging
Signal Transduction
Software
Squamous cell carcinoma
Src protein
src-Family Kinases - genetics
src-Family Kinases - metabolism
Transcriptomes
Tumors
Up-regulation
Up-Regulation - genetics
β-Catenin
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagCIkL4s2WgozEDVnxJrbjnFCLWrYgKiS60t4sv7LdA8mSbCvKz-KH8JuYcbJbcYBjHMuK5uH5ZjIPQt4UgLHdNIJb4oJlQrqSVUJzZhX3RVkGFzkWJ38-U7O5-LiQizHg1o9plds7MV3UofUYI88KsMS6zIWu3q2_M5wahX9XxxEat8kdbF2GUl0ubhwuHKecqotyyTSo9rZoRqusx7YzmoGFYmiFwaX-yzCl_v3_Bp3J-Jw8IPdH1EgPBzY_JLdi84jcHeZIXj8mP-frbpgpD1SmbU2Pzw5n1F1TS7-cFp8yAHLZ718Mk5-aVUO97TErnq5TKl7sKVbpwyrwv6MYyaffVstBMqhtAl2Cq765oFcrC4_09PzDkcy-dp7aH6v-CZmfHJ-_n7FxqALzAIU2LOagdVapKMEtdjqEacidklaWtarrCvxBp0oHqIvHOqip985LIby1FqCIq33xlOw1bROfEyqsrNC2cSutCJFrp7wOTlqtVK55NSFvtxQ166F3hkk-h1ZmoL8B-ptEf8Mn5AiJvtuJfa_TQtstzahGptDKgkHFpjW1yHlugxOOV4XikddKwSEHW5aZURl7cyM6E_J69xrUCClqm9hepj1wt2H3uAl5NrB69yUFoFDwGov9_x_-gtzLUZ4w5lwekL1NdxlfAmLZuFdJLP8AuFTk-g
  priority: 102
  providerName: ProQuest
Title Upregulation of ENAH by a PI3K/AKT/β-catenin cascade promotes oral cancer cell migration and growth via an ITGB5/Src axis
URI https://www.ncbi.nlm.nih.gov/pubmed/39511483
https://www.proquest.com/docview/3125872489
https://www.proquest.com/docview/3128324465
https://doaj.org/article/386a2840509f4202adb4b09360e0f660
Volume 29
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1NbxMxELWgCIlLxTcpJTISN2Sts2t7nWODUlIQUVUaKeJijT-25NBNlE0rys_qD-lvYrzeRHBAXListLs-jN7Ynves8Qwh7wrk2HYQUJZYD0xIW7Kh0JyB4q4oS28Dj5eTv0zVZCY-zeX8t1ZfMScslQdOwGWFVoBbaCxTUglU6uCtsCjDFQ-8UqpV6xjztmKqk1qxkfL2ioxWWROLzGiG8YjFmIsC-o8w1Fbr_zvFbEPN8WOy33FEepRse0LuhfopeZi6Rt48Iz9nq3XqII-Y0mVFx9OjCbU3FOjpSfE5Q9qW3d2ymOpUL2rqoIk58HTVJt6FhsY7-fgVvb2m8dyeXi4u0jygUHt6gcJ8851eLwBf6cn5x5HMvq4dhR-L5jmZHY_PP0xY10KBOSQ-GxZyXGOgVJAogq32fuBzqyTIslJVNUT1Z1VpkWPxUHk1cM46KYQDACQetnLFC7JXL-vwilABchgjGQcJwgeurXLaWwlaqVzzYY-83yJqVqlShmkVhlYm4W8Qf9Pib3iPjCLou5GxynX7AX1vOt-bf_m-Rw63LjPd0mtMgZRNl7nQaNHb3W9cNBFRqMPyqh2DO1msFdcjL5Ord5YUyDlRIxYH_8PC1-RRHmddPIcuD8neZn0V3iCL2dg-uV_Oyz55MBpPT8_67fTF59no2y9ap-2X
linkProvider Directory of Open Access Journals
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NjtMwELaWRQguiH8KCxgJTsiK68SOc0BoF3Zp6W6FRCv15vVfSg8kJemylIfiwIPwTIyTpisOcNtjHMuKZsbzzRePZxB6EUOMbfoeaIlxmiTcpCRLJCVaUBunqTOehsvJJ2MxmCYfZny2g352d2FCWmXnExtH7Uob_pFHMSCxTFkiszfLryR0jQqnq10LjdYsRn59DpStfj18B_p9ydjR4eTtgGy6ChALscCKeAZmp4XwHHihkc71HTOCa57mIs8zIERGpAbCDupzJ_rWGsuTxGqtAYtNbmNY9wq6CsBLA9lLZxcEL7Rvbm4zMU4kuJLuko4UUR3K3EgCiEgC6gOF_wsIm34B_w5yG7A7uoVubqJUvN-a1W2044s76Frbt3J9F_2YLqu2hz1oFZc5PhzvD7BZY40_DuNRBIFj9PsXCclWxaLAVtchCx8vm9Q_X-NQFQBGwd4qHE4O8JfFvLVErAuH51V5vvqMvy00POLh5P0Bjz5VFuvvi_oeml6KuO-j3aIs_EOEE82zgKVUc504T6URVjrDtRSCSZr10KtOomrZ1upQDceRQrXyVyB_1chf0R46CELfzgx1tpuBspqrzbZVsRQaADwUyckTRpl2JjE0iwX1NBcCFtnrVKY2m79WF6baQ8-3r2HbBonqwpdnzRzwpaFaXQ89aFW9_ZIYol5gqfGj_y_-DF0fTE6O1fFwPHqMbrBgW-F_d7qHdlfVmX8C0dLKPG1MFKPTy94TfwBQ3yLy
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lj9MwELaWrkBcEG8KCxgJTsiKm8SOc0Boy7a0FKoKdqW9Gb9SeiApSZel_CyO_Ah-E-M8ijjAbY9xLCuaGc98XzyeQehpBBhbDxzQEm0ViZlOSBoLShSnJkoSqx31l5PfzfnkJH5zyk730M_uLoxPq-x8Yu2obWH8P_IggkgskjAWaZC1aRGLo_HL9RfiO0j5k9aunUZjIjO3PQf6Vr2YHoGun4XheHT8akLaDgPEAC7YEBeCCSrOHQOOqIW1AxtqzhRLMp5lKZAjzRMNEIS6zPKBMdqwODZKKYjLOjMRrHsJ7SeeFfXQ_nA0X7zf0T3fzLm-2xQyIsCxdFd2BA8qX_RGEIiPxGMAIPR_hcW6e8C_IW8d-sbX0bUWs-LDxshuoD2X30SXmy6W21vo-8m6bDrag45xkeHR_HCC9RYrvJhGswBgZPDrB_GpV_kqx0ZVPicfr-tEQFdhXyMARsH6SuzPEfDn1bKxS6xyi5dlcb75hL-uFDzi6fHrIQs-lAarb6vqNjq5EIHfQb28yN09hGPFUh9ZqWIqto4KzY2wminBeSho2kfPO4nKdVO5Q9aMR3DZyF-C_GUtf0n7aOiFvpvpq27XA0W5lO0mlpHgCsK5L5mTxSENldWxpmnEqaMZ57DIQacy2bqCSv4x3D56snsNm9hLVOWuOKvngGf1tev66G6j6t2XRICBgbNG9_-_-GN0BfaDfDudzx6gq6E3Lf_zOzlAvU155h4CdNroR62NYvTxorfFb_5PKI0
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Upregulation+of+ENAH+by+a+PI3K%2FAKT%2F%CE%B2-catenin+cascade+promotes+oral+cancer+cell+migration+and+growth+via+an+ITGB5%2FSrc+axis&rft.jtitle=Cellular+%26+molecular+biology+letters&rft.au=Chan%2C+Xiu-Ya&rft.au=Chang%2C+Kai-Ping&rft.au=Yang%2C+Chia-Yu&rft.au=Liu%2C+Chiao-Rou&rft.date=2024-11-07&rft.issn=1689-1392&rft.eissn=1689-1392&rft.volume=29&rft.issue=1&rft.spage=136&rft_id=info:doi/10.1186%2Fs11658-024-00651-0&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1689-1392&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1689-1392&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1689-1392&client=summon